About Applied StemCell
Applied StemCell is a company based in Milpitas (United States) founded in 2008 was acquired by QHP Capital in October 2023. Applied StemCell has raised $67.52 million across 10 funding rounds from investors including Fosun, HHS and Advantech Capital. The company has 53 employees as of December 31, 2022. Applied StemCell operates in a competitive market with competitors including Biocytogen, GenOway, Interius Biotherapeutics, Champion Oncology and GemPharmatech, among others.
- Headquarter Milpitas, United States
- Employees 53 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Applied Stemcell
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$67.52 M (USD)
in 10 rounds
-
Latest Funding Round
$1.98 M (USD), Grant
Feb 01, 2020
-
Investors
Fosun
& 9 more
-
Employee Count
53
as on Dec 31, 2022
-
Acquired by
QHP Capital
(Oct 09, 2023)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Applied StemCell
Unlock access to complete
Unlock access to complete
Funding Insights of Applied StemCell
Applied StemCell has successfully raised a total of $67.52M across 10 strategic funding rounds. The most recent funding activity was a Grant round of $1.98 million completed in February 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Applied StemCell
Applied StemCell has secured backing from 10 investors, including institutional and venture fund investors. Prominent investors backing the company include Fosun, HHS and Advantech Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
PE firm focused on medicine based companies
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for Applied StemCell
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Applied StemCell
Investment portfolio details for Applied StemCell
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Applied StemCell
Detailed financials for Applied StemCell
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Applied Stemcell Comparisons
Peer comparison for Applied StemCell
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Applied StemCell
Applied StemCell operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Biocytogen, GenOway, Interius Biotherapeutics, Champion Oncology and GemPharmatech, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Integrated solutions for next-generation antibody drug development are provided.
|
|
| Locked | Locked | Locked |
Provider of transgenic rodent models and customized cell lines for preclinical development
|
|
| Locked | Locked | Locked |
Developer of gene therapies for treating multiple diseases
|
|
| Locked | Locked | Locked |
Drug response assays are performed using murine in vivo models.
|
|
| Locked | Locked | Locked |
Humanized models and drug screening technologies are developed for research.
|
Detailed competitors of Applied StemCell
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Applied Stemcell
Complete news archive for Applied StemCell
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Applied StemCell
Applied StemCell was founded in 2008 and raised its 1st funding round 2 years after it was founded.
Applied StemCell is headquartered in Milpitas, United States. It is registered at Milpitas, California, United States.
Applied StemCell is a funded company, having raised a total of $67.52M across 10 funding rounds to date.
As of Dec 31, 2022, the latest employee count at Applied StemCell is 53.
Provider of animal and cell line models as tools for drug discovery and diagnostics. Using its proprietary TARGATT gene modification technology, it makes site-specific Knockin mouse, rat, and human cell line models fast and efficient for the pharmaceutical and academic community. It focuses on the development and commercialization of mouse models, rat models, human cell line models, stem cell culture products, gene engineering in stem cells or other mammalian cells.
Applied StemCell's top competitors include Biocytogen, GenOway and Champion Oncology.
Applied StemCell has 10 investors. Key investors include Fosun, HHS, Advantech Capital, Yuan Ming Capital, and Coalescence Partners.